Paysign Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
Paysign yıllık ortalama 69.9% oranında kazançlarını artırırken, Diversified Financial sektöründe kazançlar growing at 13.5% annual. Gelirler growing yılda ortalama 25.9% oranında artmaktadır. Paysign'in özkaynak karlılığı 18.9% ve net marjı 11.4%'dir.
Anahtar bilgiler
69.87%
Kazanç büyüme oranı
70.07%
EPS büyüme oranı
| Diversified Financial Sektör Büyümesi | 6.15% |
| Gelir büyüme oranı | 25.89% |
| Özkaynak getirisi | 18.91% |
| Net Marj | 11.37% |
| Son Kazanç Güncellemesi | 31 Mar 2026 |
Yakın geçmiş performans güncellemeleri
Recent updates
Anlatı Güncellemesi • May 20
PAYS: Higher Margin Guidance And Premium P/E Framework Will Drive Repricing
Analysts have nudged their fair value estimate for Paysign up from $12.00 to $12.75, citing updated assumptions around growth, margins, and future P/E that fed into the latest price target increase highlighted in recent Street research. Analyst Commentary Recent Street research highlights a more constructive tone around Paysign, with bullish analysts pointing to the refreshed fair value estimate and updated assumptions as key supports for their views.Anlatı Güncellemesi • Apr 30
PAYS: Higher Margin Outlook Will Support Repricing On Updated Profitability Assumptions
Analysts have raised their price target on Paysign by $1 to $12, citing updated assumptions around growth, profitability, discount rate and future P/E as the main drivers of this change. Analyst Commentary Bullish analysts are highlighting the recent price target move to US$12 as a sign of growing confidence in Paysign's outlook, with updated assumptions around growth, profitability, discount rate and future P/E at the core of their thesis.Anlatı Güncellemesi • Apr 12
PAYS: Higher Margin Outlook And Raised P/E Assumption Will Support Repricing
Analysts lifted their Paysign price target by $1 to reflect slightly higher modeled revenue growth, modestly stronger profit margins, and an adjusted future P/E assumption, all under broadly consistent fair value and discount rate inputs. Analyst Commentary Bullish analysts framing the recent price target move highlight that the updated P/E assumption and slightly higher modeled revenue and margins support a higher fair value range for Paysign, while keeping discount rate inputs broadly consistent.Anlatı Güncellemesi • Mar 28
PAYS: Higher Profit Margin Outlook Will Support More Constructive Share Repricing
The analyst price target for Paysign has increased from $9.50 to $12.00, with analysts citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E as key drivers of the change. Analyst Commentary Recent research points to a more constructive view on Paysign, with bullish analysts updating their models to reflect what they see as improved fair value assumptions and a more supportive outlook for key valuation inputs such as discount rate, revenue growth, profit margin and future P/E.Analiz Makalesi • Feb 05
The Price Is Right For Paysign, Inc. (NASDAQ:PAYS) Even After Diving 27%
Paysign, Inc. ( NASDAQ:PAYS ) shareholders that were waiting for something to happen have been dealt a blow with a 27...Analiz Makalesi • Nov 16
Paysign, Inc. Just Beat EPS By 100%: Here's What Analysts Think Will Happen Next
Paysign, Inc. ( NASDAQ:PAYS ) just released its quarterly report and things are looking bullish. The company beat...Seeking Alpha • Oct 01
Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)
Summary Paysign posted strong Q2 2025 results, with 33% YoY revenue growth and robust Pharma segment momentum, driven by US tariffs and new client wins. PAYS is rated a hold, as the stock trades at fair value ($5.83), despite expected high demand for co-payment cards and expanded patient affordability programs. Pharma segment revenue surged 189% YoY, offsetting a 4.7% YoY decline in the core Plasma segment, which faces ongoing headwinds from transitioning centers. While PAYS benefits from industry tailwinds and guidance consistency, risks remain due to Plasma's weakness and Pharma revenues still lagging Plasma's overall contribution. Read the full article on Seeking AlphaAnaliz Makalesi • Aug 09
Paysign, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
NasdaqCM:PAYS 1 Year Share Price vs Fair Value Explore Paysign's Fair Values from the Community and select yours One of...
Anlatı Güncellemesi • Aug 07
Digital Payment Solutions Will Expand Healthcare Access Further
Analysts maintain a positive outlook on Paysign due to ongoing growth in its Patient Affordability segment, confidence in its pharmaceutical pipeline, and scalable model, resulting in no change to the consensus price target, which remains at $9.10. Analyst Commentary Bullish analysts highlight a strong outlook for Paysign's Patient Affordability segment, especially within the pharmaceutical industry.Analiz Makalesi • May 06
Paysign, Inc.'s (NASDAQ:PAYS) 28% Price Boost Is Out Of Tune With Earnings
Those holding Paysign, Inc. ( NASDAQ:PAYS ) shares would be relieved that the share price has rebounded 28% in the last...Analiz Makalesi • Mar 04
Paysign, Inc.'s (NASDAQ:PAYS) Share Price Not Quite Adding Up
With a median price-to-earnings (or "P/E") ratio of close to 18x in the United States, you could be forgiven for...Analiz Makalesi • Dec 27
Here's Why Paysign (NASDAQ:PAYS) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Seeking Alpha • Nov 20
Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth
Summary Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary sectors: plasma payment processing and pharma patient affordability, both offering significant growth and high gross margins. PAYS's plasma business boasts a 40% market share with steady 10-15% annual growth, while the pharma segment is expected to surpass plasma with rapid expansion. Risks include increased competition, potential loss of key customers, and limited financial resources, but catalysts like market share gains and acquisition potential bolster the investment thesis. Read the full article on Seeking Alpha
Yeni Anlatı • Sep 26
Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures
The expansion into the patient affordability segment and significant client growth, like AstraZeneca, indicates a promising area for revenue and earnings increases.Analiz Makalesi • Sep 07
Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analiz Makalesi • Aug 02
Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Paysign, Inc. ( NASDAQ:PAYS ) shareholders are probably feeling a little disappointed, since its shares fell 7.1% to...Seeking Alpha • Jun 30
Paysign: Expect Rapid Growth In Its Pharma Business
Summary Shares have risen sharply this year, reflecting solid business performance. Its pharma segment is experiencing exceptional growth and has a long runway for continued expansion. My valuation model indicates that shares have limited upside. Read the full article on Seeking AlphaAnaliz Makalesi • Apr 26
Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Paysign, Inc. ( NASDAQ:PAYS ) shares have continued their recent momentum with a 30% gain in the last month alone. The...Analiz Makalesi • Mar 29
Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analiz Makalesi • Jan 25
Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)
PaySign, Inc.'s ( NASDAQ:PAYS ) price-to-sales (or "P/S") ratio of 3.4x may not look like an appealing investment...Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Paysign nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Mar 26 | 91 | 10 | 35 | 0 |
| 31 Dec 25 | 82 | 8 | 33 | 0 |
| 30 Sep 25 | 75 | 8 | 31 | 0 |
| 30 Jun 25 | 69 | 7 | 29 | 0 |
| 31 Mar 25 | 64 | 6 | 27 | 0 |
| 31 Dec 24 | 58 | 4 | 25 | 0 |
| 30 Sep 24 | 56 | 8 | 24 | 0 |
| 30 Jun 24 | 54 | 8 | 22 | 0 |
| 31 Mar 24 | 50 | 7 | 22 | 0 |
| 31 Dec 23 | 47 | 6 | 21 | 0 |
| 30 Sep 23 | 44 | 2 | 20 | 0 |
| 30 Jun 23 | 42 | 1 | 20 | 0 |
| 31 Mar 23 | 40 | 1 | 18 | 0 |
| 31 Dec 22 | 38 | 1 | 18 | 0 |
| 30 Sep 22 | 36 | 0 | 18 | 0 |
| 30 Jun 22 | 33 | -1 | 17 | 0 |
| 31 Mar 22 | 31 | -1 | 17 | 0 |
| 31 Dec 21 | 29 | -3 | 16 | 0 |
| 30 Sep 21 | 28 | -7 | 15 | 0 |
| 30 Jun 21 | 20 | -13 | 15 | 0 |
| 31 Mar 21 | 20 | -12 | 15 | 0 |
| 31 Dec 20 | 24 | -9 | 15 | 0 |
| 30 Sep 20 | 27 | -3 | 14 | 0 |
| 30 Jun 20 | 36 | 6 | 13 | 0 |
| 31 Mar 20 | 38 | 8 | 13 | 0 |
| 31 Dec 19 | 35 | 7 | 12 | 0 |
| 30 Sep 19 | 32 | 6 | 11 | 0 |
| 30 Jun 19 | 29 | 4 | 10 | 0 |
| 31 Mar 19 | 26 | 3 | 9 | 0 |
| 31 Dec 18 | 23 | 3 | 8 | 0 |
| 30 Sep 18 | 21 | 2 | 6 | 0 |
| 30 Jun 18 | 19 | 2 | 6 | 0 |
| 31 Mar 18 | 17 | 2 | 5 | 0 |
| 31 Dec 17 | 15 | 2 | 4 | 0 |
| 30 Sep 17 | 14 | 2 | 3 | 0 |
| 30 Jun 17 | 12 | 2 | 3 | 0 |
| 31 Mar 17 | 11 | 2 | 3 | 0 |
| 31 Dec 16 | 10 | 1 | 3 | 0 |
| 30 Sep 16 | 10 | 1 | 3 | 0 |
| 30 Jun 16 | 9 | -2 | 3 | 0 |
| 31 Mar 16 | 9 | -2 | 4 | 0 |
| 31 Dec 15 | 8 | -2 | 4 | 0 |
| 30 Sep 15 | 11 | 0 | 4 | 0 |
| 30 Jun 15 | 11 | 3 | 3 | 0 |
Kaliteli Kazançlar: PAYS yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: PAYS 'nin mevcut net kar marjları (11.4%) geçen yılın (9.6%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: PAYS son 5 yılda karlı hale geldi ve kazançlarını yıllık 69.9% oranında artırdı.
Büyüme Hızlandırma: PAYS 'un son bir yıldaki kazanç büyümesi ( 70.8% ) 5 yıllık ortalamasını (yıllık 69.9% ) aşıyor.
Kazançlar vs. Sektör: PAYS geçen yılki kazanç büyümesi ( 70.8% ) Diversified Financial sektörünün 8.6% değerini aştı.
Özkaynak Getirisi
Yüksek ROE: PAYS 'nin Özsermaye Getirisi ( 18.9% ) düşük olarak değerlendiriliyor.
Varlık Getirisi
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/22 07:59 |
| Gün Sonu Hisse Fiyatı | 2026/05/22 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Paysign, Inc. 6 Bu analistlerden 5, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Gary Prestopino | Barrington Research Associates, Inc. |
| Austin Moldow | Canaccord Genuity |
| Peter Heckmann | D.A. Davidson & Co. |